Machine learning-based predictive and risk analysis using real-world data with blood biomarkers for hepatitis B patients in the malignant progression of hepatocellular carcinoma

Hepatitis B Virus (HBV) infection may lead to various liver diseases such as cirrhosis, end-stage liver complications, and Hepatocellular carcinoma (HCC). Patients with existing cirrhosis or severe fibrosis have an increased chance of developing HCC. Consequently, lifetime observation is currently a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nan, Yuemin, Zhao, Suxian, Zhang, Xiaoxiao, Xiao, Zhifeng, Guo, Ruihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791942/
https://www.ncbi.nlm.nih.gov/pubmed/36578484
http://dx.doi.org/10.3389/fimmu.2022.1031400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791942/
https://www.ncbi.nlm.nih.gov/pubmed/36578484
http://dx.doi.org/10.3389/fimmu.2022.1031400

Ejemplares similares